1. A transdermally absorbable preparation having a base and an adhesive layer that is placed on the base and which contains an adhesive agent and a drug component, where the adhesive agent contains a resin mixture containing 100 parts by weight of acrylic copolymer (A) described below, and from 0, 1 to 30 parts by weight of the acrylic copolymer (B) described below, or from 0.05 to 2 parts by weight of the polyamine compound, and where the adhesive layer further comprises an organic acid, where the acrylic copolymer (A) is an acrylic copolymer which is contains an alkyl ester of (meth) acrylic acid as the main monomer component and contains from 3 to 45% by weight of diacetone acrylamide as the necessary monomer component, but does not contain a free carboxyl group, where the acrylic copolymer (B) is an acrylic copolymer that contains (meth) acrylic acid alkyl ester as the main monomer component and contains a primary amino group and / or a carboxyhydrazide group on the side chains, but does not contain a free carboxylic acid ruppu.2. The transdermally absorbable preparation according to claim 1, containing as an organic acid at least any of lactic acid, salicylic acid, succinic acid, thioglycolic acid, maleic acid, malonic acid, adipic acid, benzoic acid, capric acid, sorbic acid, malic acid citric acid, tartaric acid, palmitic acid, fumaric acid, propionic acid, behenic acid, myristic acid and their hydrates. 3. The transdermally absorbable preparation according to claim 1, wherein the drug1. Чрескожно всасывающийся препарат, имеющий основу и адгезивный слой, который помещен на основу и который содержит адгезивный агент и лекарственный компонент,где адгезивный агент содержит смесь смол, содержащую 100 частей по массе акрилового сополимера (А), описанного ниже, и от 0,1 до 30 частей по массе акрилового сополимера (В), описанного ниже, или от 0,05 до 2 частей по массе полиаминного соединения, и где адгезивный слой дополнительно содержит органическую кислоту,где акри
